DOLAVER Intimate Wash is a topical formulation optimized for delicate skin cleansing. The 100ml specification provides sufficient volume for repeated professional or institutional use, ensuring standardized application.
The formulation is engineered for consistent viscosity and skin-safe pH balance.
REJO-E Glowing Serum is a topical formulation designed for precision application and optimized skin absorption. The 30ml format provides consistent dosing for professional or clinical use.
The formulation ensures uniform spreadability and stability across repeated applications.
SELOMA Under Eye Cream is a topical formulation designed for precise localized delivery around delicate periocular regions. The 15gm specification ensures controlled application and minimizes wastage.
The formulation provides consistent spreadability, absorption, and hydration performance tailored to professional cosmetic applications.
ELMOLIM Moisturizing Cream is a topical formulation engineered for uniform hydration across larger skin areas. The 100gm specification provides sufficient volume for repeated clinical or professional use.
The cream ensures consistent spreadability and stability during bulk handling.
INCRETON Beauty Cream is a topical formulation designed for precision application across facial and body areas. The 60gm specification allows repeated professional usage while maintaining consistent performance.
The formulation ensures smooth texture, spreadability, and stability.
ELIRASH Anti-Rash Cream is a topical formulation providing targeted relief and skin protection. The 40gm specification allows precise localized application for institutional or clinical use.
The formulation ensures consistent absorption, spreadability, and long-term stability.
Magnesium Sulphate Injection BP is a biocompatible injectable electrolyte solution delivering 50% w/v in 5ml vials, designed for rapid correction of magnesium deficiency and seizure prophylaxis.
The 50% w/v, 5ml specification allows for precise therapeutic dosing in institutional and hospital settings.
Pantoprazole injectable combipack contains 40mg per unit in sterile injectable form. Suitable for professional clinical use and bulk procurement.
Supports distributors, OEMs, and export buyers requiring standardized injectable supply with secure handling.
Magnesium Sulphate Injection BP provides a sterile 50% w/v solution in 10ml vials. Designed for professional clinical and bulk procurement use.
Suitable for distributors, institutional buyers, OEMs, and export supply requiring standardized injectable formats.
Gentamicin Injection B.P. provides 80mg per 2ml vial in a sterile injectable formulation. Designed for professional clinical settings and bulk procurement.
Suitable for distributors, institutional buyers, OEMs, and export supply chains requiring standardized handling and professional-grade injectable products.
Dexamethasone Injection USP provides 4mg per 1ml vial in sterile injectable form. Prepared for professional clinical and bulk procurement usage.
Supports distributors, institutional buyers, OEMs, and export buyers needing standardized handling and professional injectable formats.
This combipack provides sterile 40mg Omeprazole Sodium per unit in injectable form. Prepared for bulk procurement and professional clinical usage.
Designed to support distributors, OEMs, and export buyers requiring efficient handling and standardized packaging for institutional supply.
Vancomycin Hydrochloride Injection USP is a biocompatible parenteral antibiotic formulation designed for systemic bacterial infection management, delivering a precise 1gm dosage per vial for clinical reliability.
The standardized 1gm unit volume allows consistent therapeutic delivery, ensuring predictable pharmacodynamic outcomes in hospital and institutional applications.
Vancomycin Hydrochloride Injection USP is a biocompatible parenteral antibiotic formulation, delivering precise 500mg dosage per vial for systemic bacterial infection management.
The standardized 500mg volume allows repeatable dosing and predictable therapeutic performance in clinical applications.
Amikacin Injection is a biocompatible injectable formulation designed for systemic antibacterial therapy, delivering precise 100mg/2ml dosage per injection.
The 2ml standardized volume provides repeatable dosing, ensuring predictable pharmacokinetic performance in clinical settings.
Amikacin Injection is a biocompatible parenteral aminoglycoside antibiotic formulated for systemic bacterial infections, delivering precise 500mg/2ml dosage per injection.
The 2ml standardized volume ensures accurate dosing, supporting reproducible clinical outcomes in professional medical environments.
Diclofenac Sodium Injection is a biocompatible injectable formulation designed for rapid anti-inflammatory and analgesic therapy, delivering precise 75mg/1ml dosage per injection.
The 1ml standardized volume ensures consistent clinical effect while facilitating repeatable dosing in professional medical settings.
Ranitidine Injection is a biocompatible injectable formulation for targeted H2 receptor antagonism, facilitating gastric acid suppression in acute clinical applications.
The 50mg/2ml volume provides a standardized dose, enabling precise administration and predictable therapeutic efficacy.
Combipack of Ampicillin Injection is a biocompatible injectable formulation designed for systemic antibacterial therapy, integrating Ampicillin in a sterile 10ml FFS WFI diluent for precision dosing.
The 1gm active dosage within the 10ml vehicle provides standardized therapeutic volume, ensuring accurate administration and consistent pharmacodynamic activity across clinical applications.
Paraldehyde Injection B.P. is a biocompatible injectable formulation for rapid central nervous system depressant therapy, delivering 5ml dosage per vial for controlled clinical use.
The 5ml specification ensures precise administration and predictable therapeutic effect for emergency and institutional applications.
Nefopam Hydrochloride Injection is a biocompatible parenteral analgesic formulation delivering 20mg per 2ml for rapid pain management in clinical and hospital settings.
The 20mg/2ml specification ensures precise dosing and predictable therapeutic outcomes in institutional applications.
Hydrocortisone Sodium Succinate Injection is a biocompatible injectable formulation designed for rapid systemic corticosteroid delivery, providing precise 100mg dosing per vial for clinical applications.
The 100mg specification ensures standardized anti-inflammatory and immunosuppressive therapy, allowing predictable pharmacokinetics in hospital and institutional use.
Ketorolac Tromethamine Injection is a biocompatible injectable NSAID formulation delivering 30mg per 1ml vial, designed for rapid analgesic and anti-inflammatory effect in controlled clinical environments.
The 30mg/1ml specification ensures standardized dosing for predictable pain management in hospital and institutional use.
Lidocaine Injection BP is a biocompatible injectable local anesthetic delivering 2% w/v solution, designed for rapid onset analgesia and procedural anesthesia in clinical environments.
The 2% w/v specification ensures standardized anesthetic effect, suitable for surgical, diagnostic, and institutional applications.
Artesunate Injection is a biocompatible antimalarial injectable formulation delivering 120mg per pack, designed for rapid parasiticidal action in clinical and hospital settings.
The 120mg specification ensures precise therapeutic dosing, suitable for institutional and emergency use.
Triamcinolone Acetonide Injectable Suspension USP is a biocompatible pharmaceutical formulation engineered for targeted corticosteroid delivery via intramuscular or intra-articular injection.
The 40mg/1ml concentration provides a standardized clinical dosage, enabling precise administration while minimizing dosing variability and ensuring consistent therapeutic efficacy.
Tranexamic Acid Injection BP is a biocompatible injectable formulation designed to inhibit fibrinolysis and stabilize clot formation. The 100mg/ml concentration ensures precise dosing for clinical hemostatic interventions.
This standardized dosage supports rapid hemostatic control, making it suitable for surgical, trauma, and institutional applications.
Ondansetron Injection is a biocompatible parenteral formulation designed for antiemetic therapy, providing precise 8mg/4ml dosing for rapid onset of action in clinical settings.
The 4ml standardized volume ensures repeatable dosing and consistent therapeutic effect.
Artesunate Injection is a biocompatible antimalarial injectable formulation delivering 60mg per pack, designed for rapid parasiticidal action in clinical and hospital environments.
The 60mg specification ensures precise therapeutic dosing for institutional and emergency medical use.
Bulk Pharmaceuticals in this category include Active Pharmaceutical Ingredients used as base compounds in finished drug manufacturing. These materials are typically sourced by pharmaceutical manufacturers, formulators, and contract production units supplying regulated and semi-regulated markets. The category focuses on bulk pharmaceutical sourcing rather than finished dosage branding or retail packaging.
API sourcing in this category is aligned with bulk production environments where consistency, batch traceability, and documented manufacturing processes are required. Buyers typically assess suppliers based on process control standards, documentation availability, and alignment with destination-market regulatory expectations without assuming product-specific approvals.
Generic Medicines under Bulk Pharmaceuticals refer to non-branded pharmaceutical formulations supplied for institutional procurement, redistribution, or secondary manufacturing. These products are commonly sourced for public health supply chains, hospital networks, and international distributors focusing on cost-effective therapeutic availability.
Bulk generic medicines are often procured for large-scale distribution, government tenders, or OEM pharmaceutical manufacturing. Buyers typically evaluate suitability based on formulation category, dosage form grouping, and regulatory compatibility with their target markets rather than individual product performance attributes.
OTC Pharmaceuticals in this category include bulk-supplied formulations intended for over-the-counter distribution channels. These products are positioned for markets where non-prescription access is permitted and are generally sourced by wholesalers, private label marketers, and international pharmaceutical distributors.
OTC pharmaceutical sourcing at a bulk level requires attention to labeling adaptability, documentation readiness, and compliance alignment for importing regions. Buyers typically confirm export documentation processes and regulatory references applicable to their destination markets before finalizing supply arrangements.
Pharmaceutical Excipients cover non-active substances used in formulation stability, delivery, and processing. This category supports manufacturers producing tablets, capsules, injectables, and topical products where excipient quality directly affects manufacturing consistency rather than therapeutic outcomes.
Bulk excipient sourcing focuses on material consistency, contamination control, and documented sourcing practices. Buyers commonly assess excipients based on formulation compatibility, supply continuity, and adherence to recognized pharmacopeial or internal quality benchmarks relevant to their manufacturing processes.